Brettschneider J - Search Results

1

[Current cerebrospinal fluid diagnostics for pathogen-related diseases].

Süssmuth SD, Brettschneider J, Spreer A, Wick M, Jesse S, Lewerenz J, Otto M, Tumani H. Süssmuth SD, et al. Among authors: brettschneider j. Nervenarzt. 2013 Feb;84(2):229-44. doi: 10.1007/s00115-012-3701-8. Nervenarzt. 2013. PMID: 23371378 Free PMC article. Review. German.

2

Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases.

Tumani H, Teunissen C, Süssmuth S, Otto M, Ludolph AC, Brettschneider J. Tumani H, et al. Among authors: brettschneider j. Expert Rev Mol Diagn. 2008 Jul;8(4):479-94. doi: 10.1586/14737159.8.4.479. Expert Rev Mol Diagn. 2008. PMID: 18598229 Review.

3

[Cerebrospinal fluid-based diagnostics of CT-negative subarachnoid haemorrhage].

Tumani H, Petzold A, Wick M, Kühn HJ, Uhr M, Otto M, Regeniter A, Brettschneider J. Tumani H, et al. Among authors: brettschneider j. Nervenarzt. 2010 Aug;81(8):973-9. doi: 10.1007/s00115-010-2997-5. Nervenarzt. 2010. PMID: 20700683 Review. German.

4

Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases.

Brettschneider J, Widl K, Ehrenreich H, Riepe M, Tumani H. Brettschneider J, et al. Neurosci Lett. 2006 Sep 1;404(3):347-51. doi: 10.1016/j.neulet.2006.06.011. Epub 2006 Jul 3. Neurosci Lett. 2006. PMID: 16815630

5

Neurofilament heavy-chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes.

Brettschneider J, Petzold A, Süssmuth SD, Landwehrmeyer GB, Ludolph AC, Kassubek J, Tumani H. Brettschneider J, et al. Mov Disord. 2006 Dec;21(12):2224-7. doi: 10.1002/mds.21124. Mov Disord. 2006. PMID: 17013909

6

Erythropoietin in cerebrospinal fluid: age-related reference values and relevance in neurological disease.

Widl K, Brettschneider J, Schattauer D, Süssmuth S, Huber R, Ludolph AC, Tumani H. Widl K, et al. Among authors: brettschneider j. Neurochem Res. 2007 Jul;32(7):1163-8. doi: 10.1007/s11064-007-9286-0. Epub 2007 Mar 31. Neurochem Res. 2007. PMID: 17401663

7

Proteome analysis of cerebrospinal fluid in amyotrophic lateral sclerosis (ALS).

Brettschneider J, Mogel H, Lehmensiek V, Ahlert T, Süssmuth S, Ludolph AC, Tumani H. Brettschneider J, et al. Neurochem Res. 2008 Nov;33(11):2358-63. doi: 10.1007/s11064-008-9742-5. Epub 2008 May 15. Neurochem Res. 2008. PMID: 18481174

8

Biochemical markers in CSF of ALS patients.

Süssmuth SD, Brettschneider J, Ludolph AC, Tumani H. Süssmuth SD, et al. Among authors: brettschneider j. Curr Med Chem. 2008;15(18):1788-801. doi: 10.2174/092986708785133031. Curr Med Chem. 2008. PMID: 18691039 Review.

9

Cerebrospinal fluid biomarkers in Guillain-Barré syndrome--where do we stand?

Brettschneider J, Petzold A, Süssmuth S, Tumani H. Brettschneider J, et al. J Neurol. 2009 Jan;256(1):3-12. doi: 10.1007/s00415-009-0097-x. Epub 2009 Feb 16. J Neurol. 2009. PMID: 19267167 Review.

10

2D DIGE of the cerebrospinal fluid proteome in neurological diseases.

Tumani H, Lehmensiek V, Lehnert S, Otto M, Brettschneider J. Tumani H, et al. Among authors: brettschneider j. Expert Rev Proteomics. 2010 Feb;7(1):29-38. doi: 10.1586/epr.09.99. Expert Rev Proteomics. 2010. PMID: 20121474 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters